Description
Retatrutide 30MG
Retatrutide 30mg refers almost exclusively to unregulated, compounded, or research-grade vials (typically lyophilized powder for reconstitution) sold online via gray-market sources (e.g., Chinese peptide suppliers, Telegram vendors, or sites like peptidesciences.com equivalents). These are not from Lilly and lack clinical validation. Here’s expanded intel:
1. Product Specs from Sellers
- Packaging: 30mg vial (single or multi-dose) + bacteriostatic water for mixing. Claims “99%+ purity” via HPLC tests (often faked).
- Reconstitution Example (user-reported):
| Volume Added | Concentration | Suggested “Dose” (untested) |
|---|---|---|
| 3ml BAC water | 10mg/ml | 0.4ml = 4mg; 1.2ml = 12mg |
| 1.5ml BAC water | 20mg/ml | 0.2ml = 4mg; 0.6ml = 12mg |
| 1ml BAC water | 30mg/ml | 0.13ml = ~4mg (imprecise) |
- SubQ injection weekly via insulin syringe. Shelf life: 4–8 weeks refrigerated post-mix.- Price: $150–400/vial (black market pricing fluctuates).
2. User Reports (Anecdotal from Reddit r/Retatrutide, r/Peptides, Forums)
- Effects at “High Doses” (e.g., 12–24mg equivalents from 30mg vials):
| Dose Range | Weight Loss (4–12 weeks) | Pros | Cons |
|---|---|---|---|
| 4–8mg | 5–12% | Appetite suppression, energy ↑ | Mild nausea |
| 12–20mg | 10–20% | Rapid fat loss, muscle sparing | Intense GI, HR ↑ (100+ bpm) |
| 24–30mg+ | 15–25% (short-term) | Extreme hunger kill | Vomiting, dehydration, insomnia, “retatrutide flu” |
- Success Stories: Bodybuilders report 20–30lbs loss in 8 weeks + recomp (less muscle loss vs. semaglutide).
- Horror Stories: Pancreatitis flares, ER visits for dehydration, fakes causing no effects or infections.
- Half-Life: ~6 days (weekly dosing).
3. Lab Testing and Purity Risks
- Third-Party Tests (e.g., Janoshik, Peptide-Test):
- Legit batches: 95–105% purity.
- Fakes: 20–80% (contaminated with mannitol, or swapped for tirzepatide).
- Red Flags: No batch #, cloudy mix, rapid degradation, bitter taste on accidental oral.
4. Advanced Trial Data Comparison
| Drug | Max Dose | Weight Loss (48w) | A1c Drop | GI Side Effects |
|---|---|---|---|---|
| Semaglutide | 2.4mg | 15–17% | -1.9% | 40–50% |
| Tirzepatide | 15mg | 20–22% | -2.3% | 50–60% |
| Retatrutide | 12mg | 24% | -2.0% | 60–70% |
| 30mg (speculative) | N/A | ? (30%+?) | ? | Extreme |
Phase 2 source: NEJM 2023. 12mg beat tirzepatide head-to-head.
5. Risk Mitigation (If Ignoring Advice)
- Titrate: Week 1: 2mg → max 12mg over 8 weeks.
- Stacking: Common with BPC-157/TESMore for gut protection (unproven).
- Monitoring: Weekly BP/HR, electrolytes, amylase/lipase bloodwork.
- PCOS/Thyroid: Works well per reports, but screen MTC risk.
6. Sourcing Realities
| Source Type | Reliability | Cost | Risks |
|---|---|---|---|
| Clinical Trial | 100% | Free | Eligibility only |
| Compounded US Pharmacy | 80–90% | $500+/mo | Legal gray area |
| Chinese Labs (30mg vials) | 30–70% | $200/mo | Fakes, customs seizure, legal |
| Underground | <50% | $100/mo | Contaminants, no recourse |
Phase 3 Timeline: Topline data Q4 2025; approval possible 2027. Lilly aims for oral version too.
Final Warning: 30mg is Russian roulette—untested, illegal outside trials, and inferior to waiting for legit supply. Doctors report rising ER cases from peptide abuse. For personalized plans, consult via telehealth (e.g., JoinMochi or Lilly trials). Sources: ClinicalTrials.gov NCT05929066, PubMed, user aggregates (DYOR).
Reviews
There are no reviews yet.